: Leading the obesity drug market; seen as a must-own for growth-oriented portfolios.
: Artificial intelligence is doubling clinical trial success rates and streamlining drug discovery, potentially reducing R&D costs. buy healthcare stocks
The S&P 500 Health Care Index serves as the primary benchmark for the sector's performance. S&P 500 Health Care (Sector) (SP500-35) -7.85% since Jan 3, 2026 As of Apr 27, 23:34 GMT+3 • Disclaimer Apr 27, 2026 Open1,672.13 Low1,671.36 52-wk high1,872.62 High1,691.66 Prev close1,680.49 52-wk low1,482.51 💎 Top Stocks to Watch : Leading the obesity drug market; seen as
Analysts have identified several industry leaders with strong "Buy" ratings and significant upside potential for 2026: S&P 500 Health Care (Sector) (SP500-35) -7
: The global population aged 60+ is expected to double by 2050, creating massive, inelastic demand for services.
: The pioneer in robotic-assisted surgery, benefiting from the global surgical volume rebound.